Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease
Michihiro Iwaki(Yokohama City University), Atsushi Nakajima(Yokohama City University), Takuji Torimura(Omuta hospital), Miwa Kawanaka(Kawasaki Medical School), Hideyuki Hyogo(Albert Einstein College of Medicine), Haruki Usuda(Shimane University), Masato Yoneda(Yokohama City University Hospital), Kento Imajo(University of California San Diego), Shunji Nakajima(Kobe Pharmaceutical University), Yoshio Sumida(Kyoto Prefectural University of Medicine), Asako Nogami, Yuki Kasai(Yokohama City University), Anna Ozaki(Yokohama City University), Yuichiro Eguchi(Saga University), Noritoshi Kobayashi, Takaomi Kessoku(International University of Health and Welfare), Takashi Kobayashi, Hiroshi Ohno(RIKEN Center for Integrative Medical Sciences), Yoshiki Tanaka(Kobe Pharmaceutical University), Satoru Saito(Yokohama City University), Hirokazu Takahashi, Ayako Maeda(Kobe Pharmaceutical University), Takumi Kawaguchi(Kurume University), Yuji Ogawa(Yokohama City University), Koichiro Wada(Shimane University), Shinichi Aishima(Saga University), Masayoshi Kage(Junshin Gakuen University), Yasushi Honda(National Institute for Environmental Studies)
Cited by 44
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504